Inhibition of hepatocellular carcinoma growth and angiogenesis by dual silencing of NET-1 and VEGF

Dual gene targeted multimeric siRNA for combinatorial gene silencing

(2010) Soo Hyeon Lee et al.   BIOMATERIALS

Complementary Actions of Inhibitors of Angiopoietin-2 and VEGF on Tumor Angiogenesis and Growth

(2010) H. Hashizume et al.   CANCER RESEARCH

Clinicopathological Significance of Expression of Tspan-1, Jab1 and p27 in Human Hepatocellular Carcinoma

(2010) Li Chen et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma

(2009) Melanie B. Thomas et al.   JOURNAL OF CLINICAL ONCOLOGY

TSPAN1 protein expression: A significant prognostic indicator for patients with colorectal adenocarcinoma

(2009) Li Chen et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Tspan-1 is a tetraspanin preferentially expressed by mucinous and endometrioid subtypes of human ovarian carcinomas

(2008) Claus-Jürgen Scholz et al.   CANCER LETTERS

Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma

(2008) Abby B. Siegel et al.   JOURNAL OF CLINICAL ONCOLOGY

siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo

(2008) Esther Raskopf et al.   JOURNAL OF HEPATOLOGY